healthcare costs Archives - Ashvinmedicara

How US Prescription Policies Favor Profits Over Patient Care

Brian RogersJune 6, 20240175 views

In the U.S., the process of obtaining medications involves doctor visits, high costs, and limited accessibility, leading to lower customer satisfaction. Other countries with broad over-the-counter (OTC) availability enjoy higher customer satisfaction and easier access to medications. This article compares customer satisfaction, health outcomes, and economic impact between the U.S. and other countries, highlighting the need for the U.S. to consider a hybrid model that balances regulation with accessibility, and explores the potential benefits of allowing verified online pharmacies from India to ship medications to the U.S.

How Global Pharmacy Practices Compare to the U.S. System

Brian RogersJune 6, 20240186 views

This article compares the accessibility of antibiotics, erectile dysfunction medications, and acne treatments across various countries, highlighting the differences between prescription requirements and over-the-counter (OTC) availability. While the U.S. enforces strict prescription regulations, leading to higher costs and lower customer satisfaction, many other countries offer broader OTC access, resulting in greater satisfaction and lower costs. The analysis underscores the need for the U.S. to adopt a balanced approach that maintains safety while improving access to medications.

Safety or Profit? The Prescription Drug Classification Dilemma

Brian RogersJune 6, 20240206 views

The classification of prescription medications varies significantly between countries, reflecting different healthcare systems and regulatory environments. In the U.S., the FDA classifies many drugs as prescription-only based on safety and abuse potential. Conversely, countries like India and Thailand allow over-the-counter access to many of these medications. This article explores the reasons behind these differences and examines whether U.S. regulations are driven by safety concerns or commercial interests, and how reclassification could potentially reduce healthcare costs and improve access.

Why U.S. Healthcare Reforms Fail to Address Core Issues

Brian RogersJune 5, 20240141 views

In the dialogue surrounding U.S. healthcare reform, political leaders often propose strategies aimed at expanding access and reducing costs. However, many of these initiatives fall short for Americans juggling multiple jobs and high living costs. This article critically examines common healthcare proposals and why they may not effectively resolve the healthcare challenges faced by many Americans. From legislative reforms bogged down by bureaucracy to the impracticality of telehealth and workplace wellness programs, the gap between political promises and the reality of healthcare access remains significant. Real change requires addressing the root causes of healthcare inaccessibility: high costs, inequality, and inefficiency.

The False Promise of U.S. Healthcare Reform: Why Costs Keep Rising

Brian RogersJune 5, 20240138 views

Despite government-led initiatives aimed at reducing healthcare costs, such as the Affordable Care Act enhancements and drug price negotiations, these measures have largely failed to provide significant savings for the average American. This article explores the reasons behind the ineffectiveness of these programs, comparing them to the systems in other countries, and examines whether they serve more to maintain the status quo than to deliver meaningful reform.

LegitScript’s Influence: More Harm Than Good?

Brian RogersJune 5, 20240176 views

LegitScript, a private company with significant control over major tech and payment companies, influences what medications Americans can access and purchase online. This control supports big pharmaceutical companies by blocking affordable Indian generics, maintaining high drug prices. This article argues that such overreach undermines public health and calls for greater transparency and legislative intervention to ensure Americans have access to safe and affordable medications.

Commercial Protectionism vs. Affordable Pharmaceuticals: Navigating the Complex Landscape of U.S. Healthcare Policy

Brian RogersJune 5, 20240155 views

In the ongoing debate between commercial protectionism and the accessibility of affordable pharmaceuticals, the United States finds itself at a critical juncture. While the FDA’s stringent regulations on imported generics from countries like India are justified by health concerns, there is a growing perception that these measures increasingly serve commercial interests. Critics argue that the influence of Big Pharma has led to policies that prioritize corporate profits over consumer welfare, resulting in higher healthcare costs for Americans. This article explores the origins of these regulatory measures, the role of pharmaceutical lobbying, and the economic impacts of protectionism, calling for reforms to balance safety with affordability and accessibility.

The American Dream is Dead: Confronting the Harsh Realities of U.S. Healthcare

Brian RogersJune 5, 20240166 views

For generations, the United States has been celebrated as a land of freedom and opportunity, a place where anyone, regardless of their background, can achieve their dreams. This portrayal has been a beacon of hope for millions around the world, prompting countless individuals to leave their home countries in search of a better life. However, upon arrival, many are confronted with a reality starkly different from the idealized version of America they envisioned—one where the healthcare system presents not freedom, but chains. The high costs and restrictive nature of the U.S. healthcare system often leave new arrivals and long-standing citizens struggling to afford basic medical needs, leading to a profound sense of disillusionment and a call for systemic reform to align America’s healthcare practices with its foundational values of liberty and justice for all.

The Dependency Dilemma: How Government Aid Became Economic Enslavement

Brian RogersJune 4, 20240173 views

America’s welfare programs were initially designed as temporary support systems to aid individuals during economic hardships. However, over time, these programs have evolved into permanent entitlements, fostering a culture of dependency. This shift from gratitude to expectation has led to a system where both the poor and the middle class are increasingly reliant on government aid, exacerbating economic insecurities. The government’s expansion of entitlement programs, without addressing underlying economic disparities, has contributed to this dependency. To reverse this trend, comprehensive reforms are needed to create economic opportunities and make healthcare affordable, thereby restoring the foundational American belief in self-reliance and the true spirit of the American Dream.

The Corporate Cabal: Unveiling America’s Controlled Future

Brian RogersJune 4, 20240167 views

As America’s democracy faces the overwhelming influence of corporate conglomerates, a troubling future emerges where food and health are tightly controlled by a few powerful entities. This article explores the intricate connections between corporations, government bodies, and public health systems, revealing a reality where corporate interests overshadow public policy. With major corporations like Monsanto and Bayer dominating the food supply and pharmaceutical giants dictating drug availability and pricing, the lines between public health and corporate profit blur. The role of the FDA and political entities, swayed by substantial campaign contributions, further complicates the landscape. This scenario paints a future where basic needs are commodified, healthcare becomes increasingly inaccessible, and technological advancements facilitate unprecedented surveillance and control. However, grassroots movements and public advocacy offer hope for reclaiming transparency and fairness in the system.